Antibodies (Abs) to MUC1 occur naturally in both healthy subjects and cancer patients and can be induced by MUC1 peptide vaccination. We compared the specificity of natural and induced MUC1 Abs with the objective of defining an effective MUC1 vaccine for active immunotherapy of adenocarcinoma patien
Synthesis and antibody recognition of mucin 1 (MUC1)-α-conotoxin chimera
✍ Scribed by Eugenia Drakopoulou; Katalin Uray; Gábor Mező; Michael R. Price; Claudio Vita; Ferenc Hudecz
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 188 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1075-2617
No coin nor oath required. For personal study only.
✦ Synopsis
We synthesized and characterized new chimera peptides by inserting an epitope of the mucin 1 glycoprotein (MUC1) as a 'guest' sequence in the 'host' structure of h-conotoxin GI, a 13-residue peptide (ECCNPACGRHYSC) isolated from the venom of Conus geographus. The Pro-Asp-Thr-Arg (PDTR) sequence of MUC1 selected for these studies is highly hydrophilic and adopts a i-turn conformation. The h-conotoxin GI also contains a i-turn in the 8-12 region, which is stabilized by two disulphide bridges in positions 2-7 and 3-13. Thus, the tetramer sequence of h-conotoxin, Arg 9 -His-Tyr-Ser 12 , has been replaced by PDTR, comprising the minimal epitope for MUC1 specific monoclonal antibodies (MAbs) HMFG1 (PDTR) and HMFG2 (DTR). Synthesis of the chimera peptide was carried out by Fmoc strategy on (4-(2%,4%dimethoxyphenyl-aminomethyl)phenoxy) (Rink) resin and either 5,5%-dithio-bis-(2-nitrobenzoic acid) (DTNB) or air oxidation was applied for the formation of the first Cys 3 -Cys 13 or Cys 2 -Cys 7 disulphide bridge, respectively. For the second disulphide bridge, three different oxidation procedures (iodine in acetic acid, 10% DMSO/1 M HCl or tallium trifluoroacetate (Tl(tfa) 3 ) in TFA) were utilized. The HPLC purified peptides were characterized by electrospray mass spectrometry (ES-MS) and amino acid analysis. The CD spectra of the bicyclic MUC1-h-[Tyr 1 ]-conotoxin chimera peptide showed partially ordered conformation with turn character. In antibody binding studies, the RIA data showed that both the linear and the bicyclic forms of MUC1-h-[Tyr 1 ]-conotoxin chimera were recognized by MAb HMFG1 specific for PDTR sequence, while no binding was observed between MAb HMFG2 and various forms of the chimera. MAb HMFG1, using synthetic epitope conjugates or native MUC1 as target antigens, recognizes the PDTR motif more efficiently in the linear than in the bicyclic compound, but no reactivity was found with the monocyclic forms of MUC1-h-[Tyr 1 ]-conotoxin chimera, underlining the importance of certain conformers stabilized by double cyclization.
📜 SIMILAR VOLUMES
MUC1 mucin is a large complex glycoprotein expressed on normal epithelial cells in humans and overexpressed and under or aberrantly glycosylated on many malignant cancer cells which consequently allows recognition of the protein core by antibodies. In order to understand how glycosylation may modula